DEA opens federal registration for state-licensed cannabis manufacturers, distributors and labs with annual fees by tier • Prohibition groups and a pharma company ask the D.C. Circuit to block the Medicare hemp coverage plan • TTB opens comments on brewery records and beer labeling collections

NEW REALM BREWING

Daily Compliance Brief

▶  Listen to today's brief (~2 min)

Vol. 1 • Edition 55 • Wednesday, October 7, 2026 • Alcohol & Hemp/THC Regulation • Federal + All 50 States

Good morning — here's the regulatory picture for alcohol and hemp/THC beverages, readable in about three minutes. Every headline links to the original source.

Top Story

DEA opens federal registration for state-licensed cannabis manufacturers, distributors and testing labs — annual fees set by tier

FEDERAL • Marijuana Moment • Oct 6

The Drug Enforcement Administration launched specialized DEA Form 225 registration forms for state-licensed medical cannabis manufacturers, distributors and analytical testing labs under the Schedule III framework, asking applicants to identify their state licenses and disclose criminal and disciplinary history. License-fee call-out — the federal registration fees are annual, per registration, for every supply-chain tier: cultivators (bulk manufacturers) and manufacturers/processors $3,699; distributors $1,850; analytical labs $296; and retail dispensaries, whose portal opened April 29, $794. These federal fees sit on top of existing state license fees.

Why it matters: Any state-licensed cannabis partner in your supply chain — processor, distributor, lab or store — now has a new federal registration to obtain and budget for: roughly $3,700 a year per manufacturing registration, $1,850 per distribution registration and $794 per dispensing registration, before state fees.

Federal

Prohibition groups and pharma company ask D.C. Circuit to block Medicare hemp coverage plan

FEDERAL • Marijuana Moment • Oct 6

Smart Approaches to Marijuana, allied groups and MMJ International Holdings filed an appeals brief asking the D.C. Circuit to revive their challenge to the administration's plan giving eligible Medicare beneficiaries up to $500 a year toward low-THC hemp products; they argue the lower court wrongly denied them standing, while the government says the plan creates no new spending or entitlements. The government's response brief is due November 4.

TTB opens comment period on brewery records, beer labeling and excise-tax paperwork

FEDERAL • Federal Register (TTB) • Oct 6

TTB published its latest Paperwork Reduction Act notice inviting comments by December 7 on a slate of information collections, including brewery records (OMB 1513-0058), beer labeling requirements, hard cider tax-class label statements, the CBMA import refund program and a combined excise-tax return pilot.

Why it matters: This is the formal channel to tell TTB where brewery recordkeeping, labeling and CBMA refund paperwork costs time — comments are due December 7.

Attorneys: Southern Glazer's bribery probe could serve as template for future middle-tier investigations

FEDERAL • Brewbound • Oct 5

Julian André, a partner at McDermott Will & Schulte, said during a firm webinar that federal agencies could use the Southern Glazer's Wine & Spirits bribery investigation as a template for examining pay-to-play arrangements in beverage distribution; the FTC already monitors the company's chain pricing under a settlement. Why it matters: Distributor pricing, incentive and slotting practices face closer federal scrutiny — worth a review of promotional arrangements on both sides of the three-tier system.

Around the States

Massachusetts: governor and congresswoman urge votes against Question 8 cannabis-sales repeal

MASSACHUSETTS • Marijuana Moment • Oct 6

Question 8 on the November ballot would repeal the rules allowing commercial recreational cannabis sales and home cultivation while keeping possession legal and the medical program intact. Rep. Ayanna Pressley (D-MA) and Gov. Maura Healey (D) each said they will vote no, with Healey calling cannabis "an important industry"; Cannabis Control Commission Chair Chris Harding said repeal "could eliminate thousands of jobs, hundreds of businesses and billions in tax revenue." Backers of the measure seek to end the commercial market statewide; recent polling reported 61% of likely voters opposed and 27% in support. Why it matters: A yes vote would close the roughly $10-billion-to-date Massachusetts adult-use retail channel — a direct market-access question for any beverage or hemp partner exposed to that state.

On the Radar

December 11, 2026 — The federal limit of 0.4 mg total THC per container for hemp-derived products takes effect (extended from November 12 by September's funding bill). Rhode Island's cannabis commission says updated licensee guidance is coming; more states are expected to follow.

Late October — Virginia's Cannabis Control Authority preliminary-feedback window on its draft adult-use retail regulations; final rules are due in December, with license applications opening February 1, 2027.

November 4 — The government's response brief is due in the D.C. Circuit challenge to the Medicare hemp coverage plan (above), a case watched for how courts treat standing in hemp-program disputes.

Jeremy Barnes | Chief Financial Officer, New Realm Brewing Co.

Prepared for New Realm's leadership team and valued partners. This brief is for general informational purposes only and is not legal advice; it is compiled with AI assistance from the linked sources — please confirm details at the link before acting on them.

Subscribe   Unsubscribe

Buttons not working? Reply to this email with the word subscribe or unsubscribe. Requests are processed automatically each morning before send.

Read online & browse the archive: compliance.newrealmbrewing.com • Listen & follow: Apple Podcasts • Spotify • Amazon Music • All apps

» jbarnes@newrealmbrewing.com

» newrealmbrewing.com

» Facebook | Instagram | Twitter | LinkedIn

Audio transcript (~2 min read)

This is the New Realm Compliance Brief, Volume One, Edition Fifty-Five, for Wednesday, October Seventh.

Our top story. The Drug Enforcement Administration has opened federal registration for state-licensed medical cannabis manufacturers, distributors, and testing labs under the new Schedule Three framework. Applicants use an updated Form Two Twenty-Five, list their state licenses, and disclose any criminal or disciplinary history. The annual federal fees run by tier: three thousand six hundred ninety-nine dollars for cultivators and manufacturers, one thousand eight hundred fifty dollars for distributors, two hundred ninety-six dollars for analytical labs, and seven hundred ninety-four dollars for dispensaries, whose portal opened back in April. These federal fees come on top of existing state license fees, so any cannabis partner in a supply chain now has a new annual registration to budget for.

In other federal news, prohibition groups and a pharmaceutical company filed a brief asking the D.C. Circuit to revive their challenge to the Medicare hemp coverage plan, which offers eligible beneficiaries up to five hundred dollars a year toward low-THC hemp products. The government's response is due November fourth. And the Alcohol and Tobacco Tax and Trade Bureau opened a comment period, running through December seventh, on brewery records, beer labeling, and excise tax paperwork requirements.

Also worth noting: attorneys at McDermott Will and Schulte said the Southern Glazer's bribery investigation could serve as a template for future federal probes of pay-to-play practices in beverage distribution.

Around the states, Massachusetts Governor Maura Healey and Congresswoman Ayanna Pressley each said they will vote no on Question Eight, which would repeal commercial recreational cannabis sales in November's election. Recent polling showed sixty-one percent of likely voters opposed.

On the radar: the federal hemp THC limit takes effect December eleventh, and Virginia's preliminary-feedback window on draft adult-use retail rules arrives in late October.

Full details and source links are in today's email. This update is for general information only — it is not legal advice.